Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.23.1
Earnings Per Share (Tables)
9 Months Ended
Mar. 31, 2023
Notes Tables  
Schedule of the calculation of basic and diluted earnings per share

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Quarter Ended

Nine Months Ended

March 31, 

March 31, 

    

2023

    

2022

2023

    

2022

Earnings per share – basic:

Net earnings, including noncontrolling interest

$

70,218

 

$

60,144

$

209,958

 

$

201,184

Less net earnings (loss) attributable to noncontrolling interest

-

 

(595)

179

 

(9,343)

Net earnings attributable to Bio-Techne

$

70,218

$

60,739

$

209,779

$

210,527

Income allocated to participating securities

 

(16)

 

(25)

 

(52)

 

(95)

Income available to common shareholders

$

70,202

$

60,714

$

209,727

$

210,432

Weighted-average shares outstanding – basic

 

157,311

 

157,087

 

157,071

 

156,899

Earnings per share – basic

$

0.45

$

0.39

$

1.34

$

1.34

Earnings per share – diluted:

 

  

 

  

 

  

 

  

Net earnings, including noncontrolling interest

$

70,218

$

60,144

$

209,958

$

201,184

Less net earnings (loss) attributable to noncontrolling interest

(595)

179

(9,343)

Net earnings attributable to Bio-Techne

$

70,218

$

60,739

$

209,779

$

210,527

Income allocated to participating securities

 

(16)

 

(25)

 

(52)

 

(95)

Income available to common shareholders

$

70,202

$

60,714

$

209,727

$

210,432

Weighted-average shares outstanding – basic

 

157,311

 

157,087

 

157,071

 

156,899

Dilutive effect of stock options and restricted stock units

 

4,304

 

6,787

 

4,697

 

7,393

Weighted-average common shares outstanding – diluted

 

161,615

 

163,874

 

161,768

 

164,292

Earnings per share – diluted

$

0.43

$

0.37

$

1.30

$

1.28